Clinical Trials
2 trialsNCT07519564 2026-04-09
A Phase I Clinical Study to Evaluate the PK, PD, Efficacy, and Safety of GB18 Injection in Patients With Tumor Cachexia
Kexing Biopharm Co., Ltd.
Phase 1 Not yet recruiting
NCT07237464 2025-11-19
To Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of GB18 Injection in Healthy Participants
Kexing Biopharm Co., Ltd.
Phase 1 Recruiting